End-of-day quote
Shenzhen S.E.
03:30:00 15/05/2024 am IST
|
5-day change
|
1st Jan Change
|
8.59
CNY
|
+0.12%
|
|
-4.98%
|
+4.00%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,989
|
6,204
|
5,166
|
8,096
|
8,570
|
-
|
-
|
Enterprise Value (EV)
1 |
5,989
|
6,204
|
5,166
|
8,096
|
8,570
|
8,570
|
8,570
|
P/E ratio
|
25.5
x
|
19.7
x
|
16
x
|
35.1
x
|
13.1
x
|
9.79
x
|
8.45
x
|
Yield
|
-
|
-
|
-
|
1.82%
|
3.26%
|
4.35%
|
4.37%
|
Capitalization / Revenue
|
1.48
x
|
-
|
-
|
1.97
x
|
1.84
x
|
1.65
x
|
1.57
x
|
EV / Revenue
|
1.48
x
|
-
|
-
|
1.97
x
|
1.84
x
|
1.65
x
|
1.57
x
|
EV / EBITDA
|
16.7
x
|
-
|
-
|
18.1
x
|
7.6
x
|
5.98
x
|
5.28
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.67
x
|
-
|
-
|
2.19
x
|
2.06
x
|
1.79
x
|
1.64
x
|
Nbr of stocks (in thousands)
|
8,99,239
|
9,72,448
|
9,80,204
|
9,80,204
|
9,97,663
|
-
|
-
|
Reference price
2 |
6.660
|
6.380
|
5.270
|
8.260
|
8.590
|
8.590
|
8.590
|
Announcement Date
|
04/02/20
|
25/02/22
|
27/02/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,058
|
-
|
-
|
4,120
|
4,665
|
5,199
|
5,452
|
EBITDA
1 |
358.1
|
-
|
-
|
448.5
|
1,128
|
1,434
|
1,624
|
EBIT
1 |
255.9
|
-
|
-
|
214.1
|
648
|
930.5
|
1,055
|
Operating Margin
|
6.3%
|
-
|
-
|
5.2%
|
13.89%
|
17.9%
|
19.35%
|
Earnings before Tax (EBT)
1 |
263.4
|
-
|
-
|
217
|
659.3
|
943.2
|
1,065
|
Net income
1 |
236
|
291.5
|
328.4
|
235.6
|
659.5
|
885.5
|
1,029
|
Net margin
|
5.82%
|
-
|
-
|
5.72%
|
14.14%
|
17.03%
|
18.88%
|
EPS
2 |
0.2610
|
0.3242
|
0.3296
|
0.2350
|
0.6550
|
0.8775
|
1.017
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1500
|
0.2800
|
0.3733
|
0.3750
|
Announcement Date
|
04/02/20
|
25/02/22
|
27/02/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.2%
|
-
|
10.2%
|
6.37%
|
15.3%
|
18.2%
|
19%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.5%
|
7.12%
|
7.37%
|
Assets
1 |
-
|
-
|
-
|
-
|
11,991
|
12,437
|
13,973
|
Book Value Per Share
2 |
2.490
|
-
|
-
|
3.770
|
4.180
|
4.790
|
5.250
|
Cash Flow per Share
2 |
0.2000
|
-
|
-
|
0.6400
|
0.9600
|
0.9900
|
1.100
|
Capex
1 |
-
|
-
|
-
|
975
|
838
|
700
|
690
|
Capex / Sales
|
-
|
-
|
-
|
23.67%
|
17.96%
|
13.46%
|
12.65%
|
Announcement Date
|
04/02/20
|
25/02/22
|
27/02/23
|
01/04/24
|
-
|
-
|
-
|
Last Close Price
8.59
CNY Average target price
12.66
CNY Spread / Average Target +47.38% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.00% | 1.18B | | +1.84% | 3.59B | | -19.91% | 2.16B | | -9.22% | 1.95B | | +4.48% | 1.89B | | +0.55% | 1.71B | | -2.68% | 1.31B | | -19.72% | 1.07B | | +0.86% | 1.04B | | -11.39% | 886M |
Pesticide
|